References
- JonesGBiochemistry and metabolism of vitamin DRenzHTauberRAdvances in Clinical Chemistry and Laboratory MedicineBerlin, GermanyDeGruyter2012
- PikeJWGenome-wide principles of gene regulation by the vitamin D receptor and its activating ligandMol Cell Endocrinol201134731021664239
- JonesGProsserDEKaufmannM25-hydroxyvitamin D-24-hydroxylase (CYP24a1): its important role in the degradation of vitamin DArch Biochem Biophys201252391822100522
- AndersonLNCotterchioMKnightJABorgidaAGallingerSClearySPGenetic variants in vitamin D pathway genes and risk of pancreas cancer: results from a population-based case-control study in Ontario, CanadaPLoS One20138e6676823826131
- ChenGKimSHKingANCYP24a1 is an independent prognostic marker of survival in patients with lung adenocarcinomaClin Cancer Res20111781782621169243
- JohnsonCSChungITrumpDLEpigenetic silencing of CYP24 in the tumor microenvironmentJ Steroid Biochem Mol Biol201012133834220304059
- PariseRAEgorinMJKanterewiczBCYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancerInt J Cancer20061191819182816708384
- AlbertsonDGYlstraBSegravesRQuantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogeneNat Genet20002514414610835626
- WhitlatchLWYoungMVSchwartzGG25-hydroxyvitamin D- 1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transferJ Steroid Biochem Mol Biol20028113514012137802
- HorváthHCLakatosPKósaJPThe candidate oncogene CYP24a1: a potential biomarker for colorectal tumorigenesisJ Histochem Cytochem20105827728519901270
- HöbausJHummelDMThiemUIncreased copy number and not DNA hypomethylation causes overexpression of the candidate proto – oncogene CYP24a1 in colorectal cancerInt J Cancer20131331380138823463632
- KosaJPHorvathPWolflingJCYP24a1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cellsWorld J Gastroenterol2013192621262823674869
- ZeljicKSupicGStamenkovicRMJovicNKozomaraRMagicZVitamin D receptor, CYP27b1 and CYP24a1 genes polymorphisms association with oral cancer risk and survivalJ Oral Pathol Med20124177978722612324
- KellyJLDrakeMTFredericksenZSEarly life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin’s lymphomaCancer Causes Control2012231017102922544453
- Penna-MartinezMRamos-LopezESternJImpaired vitamin D activation and association with CYP24a1 haplotypes in differentiated thyroid carcinomaThyroid20122270971622690899
- BeutenJGelfondJAFrankeJLSingle and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancerCancer Epidemiol Biomarkers Prev2009181869188019505920
- HolickCNStanfordJLKwonEMOstranderEANejentsevSPetersUComprehensive association analysis of the vitamin D pathway genes, VDR, CYP27b1, and CYP24a1, in prostate cancerCancer Epidemiol Biomarkers Prev2007161990199917932346
- HoltSKKwonEMPetersUOstranderEAStanfordJLVitamin D pathway gene variants and prostate cancer riskCancer Epidemiol Biomarkers Prev2009181929193319454612
- OhJJByunSSLeeSEGenetic variants in the CYP24a1 gene are associated with prostate cancer risk and aggressiveness in a Korean study populationProstate Cancer Prostatic Dis20141714915624492489
- AndersonLNCotterchioMColeDEKnightJAVitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in OntarioCancer Epidemiol Biomarkers Prev2011201708171721693626
- McCulloughMLStevensVLDiverWRVitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control studyBreast Cancer Res20079R917244366
- StangACritical evaluation of the Newcastle-Ottawa Scale for the assessment of the quality of nonrandomized studies in meta-analysesEur J Epidemiol20102560360520652370
- HigginsJPThompsonSGQuantifying heterogeneity in a meta-analysisStat Med2002211539155812111919
- HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ200332755756012958120
- BeggCBMazumdarMOperating characteristics of a rank correlation test for publication biasBiometrics199450108811017786990
- EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ19973156296349310563
- HendersonBEBernsteinLRossRKHormones and the etiology of cancerBastRCKufeDWPollockREHolland-Frei Cancer MedicineHamilton, ON, CanadaBC Decker2000
- FlanaganJNYoungMVPersonsKSVitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin DAnticancer Res2006262567257216886665
- MasudaSProsserDEGuoYDKaufmannMJonesGGeneration of a homology model for the human cytochrome p450, CYP24a1, and the testing of putative substrate binding residues by site-directed mutagenesis and enzyme activity studiesArch Biochem Biophys200746017719117224124
- AnnaloraAJBobrovnikov-MarjonESerdaRHybrid homology modeling and mutational analysis of cytochrome p450c24a1 (CYP24a1) of the vitamin D pathway: insights into substrate specificity and membrane bound structure-functionArch Biochem Biophys200746026227317207766
- OnenIHEkmekciAErogluMKonacEYesilSBiriHAssociation of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancerExp Biol Med200823316081614
- RoffAWilsonRTA novel SNP in a vitamin D response element of the CYP24a1 promoter reduces protein binding, transactivation, and gene expressionJ Steroid Biochem Mol Biol2008112475418824104
- InglesSARossRKYuMCAssociation of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptorJ Natl Cancer Inst1997891661708998186
- AzadAKBairatiIQiuXGenetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patientsInt J Cancer20121322520252723169318
- FuhrmanBJFreedmanDMBhattiPSunlight, polymorphisms of vitamin D-related genes and risk of breast cancerAnticancer Res20133354355123393347
- HoltSKKwonEMKoopmeinersJSVitamin D pathway gene variants and prostate cancer prognosisProstate2010701448146020687218
- ChenTCHolickMFLokeshwarBLBurnsteinKLSchwartzGGEvaluation of vitamin D analogs as therapeutic agents for prostate cancerVitamin D Analogs in Cancer Prevention and TherapyNew York, NY, USASpringer2003